These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa. Inamadar AC Dermatol Ther; 2020 Nov; 33(6):e14279. PubMed ID: 32888385 [TBL] [Abstract][Full Text] [Related]
6. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)]. Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283 [TBL] [Abstract][Full Text] [Related]
7. A short RNA molecule and tumour aggressiveness in people with epidermolysis bullosa. Br J Dermatol; 2023 Dec; 190(1):e9. PubMed ID: 38124517 [No Abstract] [Full Text] [Related]
8. Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa within the same family: two phenotypes associated with a COL7A1 mutation. Murase K; Kanoh H; Ishii N; Hashimoto T; Nakano H; Sawamura D; Seishima M Acta Derm Venereol; 2011 Oct; 91(6):730-1. PubMed ID: 21629976 [No Abstract] [Full Text] [Related]
9. Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa. Chambelland A; Devos C; Casagrande F; Chiaverini C Orphanet J Rare Dis; 2020 Dec; 15(1):338. PubMed ID: 33261637 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of epidermolysis bullosa in Scotland. Horn HM; Priestley GC; Eady RA; Tidman MJ Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958 [TBL] [Abstract][Full Text] [Related]
12. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Uitto J; Richard G Clin Dermatol; 2005; 23(1):33-40. PubMed ID: 15708287 [TBL] [Abstract][Full Text] [Related]
13. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study. Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936 [TBL] [Abstract][Full Text] [Related]
14. [Epidermolysis bullosa hereditaria dystrophica (Hallopeau-Siemens). Case report and therapy trial with (+)-cyanidanol-3 in 3 patients]. Schurig V; Krieg T; Landthaler M; Braun-Falco O Hautarzt; 1987 Oct; 38(10):619-21. PubMed ID: 3679817 [TBL] [Abstract][Full Text] [Related]
15. Complex genetic models in dystrophic epidermolysis bullosa families with marked intra-familial phenotypic heterogeneity. Chen F; Wang Y; Wang X; Yao Z; Li M J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e550-e553. PubMed ID: 35181940 [No Abstract] [Full Text] [Related]
17. EPIDERMOLYSIS BULLOSA. WITH A CASE REPORT ON EPIDERMOLYSIS BULLOSA DYSTROPHICA IN ONE OF A PAIR OF TWINS. PATNAIK R Indian J Pediatr; 1964 Mar; 31():81-4. PubMed ID: 14147902 [No Abstract] [Full Text] [Related]
18. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry. Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C; Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016 [TBL] [Abstract][Full Text] [Related]
19. Epidermolysis bullosa (EB) pruriginosa associated with recessive homozygous mutations in COL7A1: case report of a rare EB genotype-phenotype. O'Connor C; Heffron C; McGrath J; O'Shea S; Bourke J J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e501-e504. PubMed ID: 32250485 [No Abstract] [Full Text] [Related]